Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof
US9567572B2 · kind B2 · utility
1Cited by
10References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2014 |
| Grant date | Feb 14, 2017 |
| Priority date | — |
| Expiry date | Dec 17, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/06004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides compositions of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase (GALNS), and pharmaceutical compositions and formulations thereof, methods of producing and purifying GALNS, and its use in the diagnosis, prophylaxis, or treatment of diseases and conditions, including particularly lysosomal storage diseases that are caused by, or associated with, a deficiency in the GALNS enzyme, e.g., Mucopolysaccharidosis IVa (MPS IVa or Morquio A syndrome).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.